drugset / Trial / NCT01146197

Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics

NCT01146197

Phase 1/2 Completed 33 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedCrossoverOpen-labelTreatment

Summary

Gitelman syndrome is a rare renal disease where the kidneys are unable to normally retain some salts (sodium, potassium and magnesium). Main consequences of these renal leaks of salts are a tendency toward low blood pressure, hypokalemia and hypomagnesemia both contributing to cardiac and muscles symptoms.

Timeline

Start
2010-02
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 10 mg
Subject Amiloride Small molecule 20 mg
Subject Eplerenone Unknown 50 mg
Subject Eplerenone Unknown 150 mg
Subject Indomethacin Small molecule 75 mg
Background Magnesium Sulfate Other / unclassified Oral
Background Omeprazole Other / unclassified
Background potassium Small molecule Oral

Indications